LIVANOVA PLC (LIVN) — insider trading
Health Care · NASDAQ
LIVANOVA PLC (LIVN) has 51 reported SEC Form 4 insider transactions in our data, including 6 open-market sales among the most recent 51 (latest 2026-09-15).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Liddy Anne M. | Officer (Chief Legal Officer) | Grant / award / vesting (derivative) | 6,291 | — | $0 | Form 4 |
| 2026-09-10 | Bianchi Francesco | Director | Open-market sale | 3,500 | $78.01 | $273.0K | Form 4 |
| 2026-09-04 | Story Brooke | Director | Open-market sale | 2,300 | $81.42 | $187.3K | Form 4 |
| 2026-08-31 | Bianchi Francesco | Director | Open-market sale | 1,650 | $79.72 | $131.5K | Form 4 |
| 2026-08-11 | Tezel Ahmet | Officer (Chief Innovation Officer) | Option exercise / conversion (derivative) | 12,692 | — | $0 | Form 4 |
| 2026-08-11 | Tezel Ahmet | Officer (Chief Innovation Officer) | Open-market sale | 2,675 | $77.74 | $207.9K | Form 4 |
| 2026-08-11 | Tezel Ahmet | Officer (Chief Innovation Officer) | Shares withheld for taxes / exercise cost | 1,428 | $77.86 | $111.2K | Form 4 |
| 2026-08-11 | Tezel Ahmet | Officer (Chief Innovation Officer) | Disposition to the issuer | 8,589 | $77.86 | $668.7K | Form 4 |
| 2026-08-11 | Tezel Ahmet | Officer (Chief Innovation Officer) | Option exercise / conversion | 12,692 | $52.68 | $668.6K | Form 4 |
| 2026-06-15 | Zurbay Donald | Director | Grant / award / vesting (derivative) | 2,383 | — | $0 | Form 4 |
| 2026-06-15 | Zurbay Donald | Director | Option exercise / conversion (derivative) | 2,560 | — | $0 | Form 4 |
| 2026-06-15 | Zurbay Donald | Director | Shares withheld for taxes / exercise cost | 308 | $79.70 | $24.5K | Form 4 |
| 2026-06-15 | Zurbay Donald | Director | Option exercise / conversion | 2,560 | — | $0 | Form 4 |
| 2026-06-15 | Story Brooke | Director | Grant / award / vesting (derivative) | 2,383 | — | $0 | Form 4 |
| 2026-06-15 | Story Brooke | Director | Option exercise / conversion (derivative) | 4,042 | — | $0 | Form 4 |
| 2026-06-15 | Story Brooke | Director | Shares withheld for taxes / exercise cost | 486 | $79.70 | $38.7K | Form 4 |
| 2026-06-15 | Story Brooke | Director | Option exercise / conversion | 4,042 | — | $0 | Form 4 |
| 2026-06-15 | Enxing Seng Stacy | Director | Grant / award / vesting (derivative) | 2,383 | — | $0 | Form 4 |
| 2026-06-15 | Enxing Seng Stacy | Director | Option exercise / conversion (derivative) | 4,042 | — | $0 | Form 4 |
| 2026-06-15 | Enxing Seng Stacy | Director | Shares withheld for taxes / exercise cost | 486 | $79.70 | $38.7K | Form 4 |
| 2026-06-15 | Enxing Seng Stacy | Director | Option exercise / conversion | 4,042 | — | $0 | Form 4 |
| 2026-06-15 | KOZY WILLIAM A | Director | Grant / award / vesting (derivative) | 2,383 | — | $0 | Form 4 |
| 2026-06-15 | KOZY WILLIAM A | Director | Option exercise / conversion (derivative) | 5,681 | — | $0 | Form 4 |
| 2026-06-15 | KOZY WILLIAM A | Director | Shares withheld for taxes / exercise cost | 682 | $79.70 | $54.4K | Form 4 |
| 2026-06-15 | KOZY WILLIAM A | Director | Option exercise / conversion | 5,681 | — | $0 | Form 4 |
| 2026-06-15 | Nygaard-Andersen Jette | Director | Grant / award / vesting (derivative) | 2,383 | — | $0 | Form 4 |
| 2026-06-15 | Tezel Ahmet | Officer (Chief Innovation Officer) | Option exercise / conversion (derivative) | 2,965 | — | $0 | Form 4 |
| 2026-06-15 | Tezel Ahmet | Officer (Chief Innovation Officer) | Shares withheld for taxes / exercise cost | 1,032 | $79.70 | $82.3K | Form 4 |
| 2026-06-15 | Tezel Ahmet | Officer (Chief Innovation Officer) | Option exercise / conversion | 2,965 | — | $0 | Form 4 |
| 2026-06-15 | Barry James Christopher | Director | Grant / award / vesting (derivative) | 2,383 | — | $0 | Form 4 |
| 2026-06-15 | Barry James Christopher | Director | Option exercise / conversion (derivative) | 4,042 | — | $0 | Form 4 |
| 2026-06-15 | Barry James Christopher | Director | Shares withheld for taxes / exercise cost | 486 | $79.70 | $38.7K | Form 4 |
| 2026-06-15 | Barry James Christopher | Director | Option exercise / conversion | 4,042 | — | $0 | Form 4 |
| 2026-06-15 | PODLOGAR SUSAN M | Director | Grant / award / vesting (derivative) | 2,383 | — | $0 | Form 4 |
| 2026-06-15 | PODLOGAR SUSAN M | Director | Option exercise / conversion (derivative) | 4,042 | — | $0 | Form 4 |
| 2026-06-15 | PODLOGAR SUSAN M | Director | Shares withheld for taxes / exercise cost | 486 | $79.70 | $38.7K | Form 4 |
| 2026-06-15 | PODLOGAR SUSAN M | Director | Option exercise / conversion | 4,042 | — | $0 | Form 4 |
| 2026-06-15 | Bianchi Francesco | Director | Grant / award / vesting (derivative) | 2,383 | — | $0 | Form 4 |
| 2026-06-15 | Bianchi Francesco | Director | Option exercise / conversion (derivative) | 4,042 | — | $0 | Form 4 |
| 2026-06-15 | Bianchi Francesco | Director | Open-market sale | 1,200 | $80.19 | $96.2K | Form 4 |
| 2026-06-15 | Bianchi Francesco | Director | Shares withheld for taxes / exercise cost | 486 | $79.70 | $38.7K | Form 4 |
| 2026-06-15 | Bianchi Francesco | Director | Option exercise / conversion | 4,042 | — | $0 | Form 4 |
| 2026-06-15 | SCHERMERHORN TODD C | Director | Grant / award / vesting (derivative) | 2,383 | — | $0 | Form 4 |
| 2026-06-15 | SCHERMERHORN TODD C | Director | Option exercise / conversion (derivative) | 4,042 | — | $0 | Form 4 |
| 2026-06-15 | SCHERMERHORN TODD C | Director | Shares withheld for taxes / exercise cost | 486 | $79.70 | $38.7K | Form 4 |
| 2026-06-15 | SCHERMERHORN TODD C | Director | Option exercise / conversion | 4,042 | — | $0 | Form 4 |
| 2026-06-15 | WILVER PETER M | Director | Grant / award / vesting (derivative) | 2,383 | — | $0 | Form 4 |
| 2026-06-15 | WILVER PETER M | Director | Option exercise / conversion (derivative) | 4,042 | — | $0 | Form 4 |
| 2026-06-15 | WILVER PETER M | Director | Shares withheld for taxes / exercise cost | 486 | $79.70 | $38.7K | Form 4 |
| 2026-06-15 | WILVER PETER M | Director | Option exercise / conversion | 4,042 | — | $0 | Form 4 |
| 2026-05-26 | Bianchi Francesco | Director | Open-market sale | 1,800 | $75.75 | $136.3K | Form 4 |
Ask the chat about LIVN's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: LIVANOVA PLC (LIVN).
Last updated 2026-09-15 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.